Thinking About Hormone Therapy? Here's What Every Woman Should Know

If you've ever been told that hormone replacement therapy (HRT) is "too dangerous," chances are that advice traces back to one study published more than 20 years ago.

In 2002, the Women's Health Initiative (WHI) changed the way doctors viewed hormone therapy almost overnight. Millions of women stopped taking HRT, prescribing rates plummeted, and many women were left to suffer through hot flashes, night sweats, poor sleep, and other menopause symptoms because they believed hormone therapy wasn't safe.

But science didn't stop in 2002.

Over the last two decades, researchers have continued studying hormone therapy. As we've learned more, we've also realized that many of the fears surrounding HRT were based on applying the results of one study far more broadly than they should have been.

In November 2025, the FDA officially removed the boxed warning from menopausal hormone therapy products, acknowledging that the original warning no longer reflected the current scientific evidence.

So what actually happened, and what does it mean if you're considering hormone therapy today?

Understanding the Women's Health Initiative

The Women's Health Initiative was an important study, and it answered an important question.

Researchers wanted to know whether hormone therapy could prevent chronic diseases such as heart disease in postmenopausal women.

What many people don't realize is that the study was not designed to evaluate hormone therapy for women who were newly menopausal and seeking relief from symptoms like hot flashes, night sweats, or sleep disturbances.

The women in the study were also much older than the average woman who starts hormone therapy today. The average participant was 63 years old, and many were more than a decade past menopause. The study also evaluated a specific oral estrogen (conjugated equine estrogen) and synthetic progestin that differ from the bioidentical estradiol and micronized progesterone commonly prescribed today.

Those differences matter.

Does Hormone Therapy Increase Your Risk of Heart Disease?

This is one of the most common concerns I hear from patients.

The answer is more nuanced than a simple yes or no.

The original WHI did find a modest increase in heart disease risk among older women taking that specific combination of conjugated equine oral estrogen and synthetic progestin. However, later analyses painted a much different picture.

For healthy women who begin hormone therapy before age 60 or within 10 years of menopause, current evidence suggests hormone therapy has a favorable benefit-risk profile. Some studies have even shown lower rates of coronary heart disease and reduced overall mortality in appropriately selected women who start treatment earlier in menopause.

This concept is known as the timing hypothesis. Starting hormone therapy earlier appears to have different effects than starting it decades after menopause, when cardiovascular disease may already be present.

What About Breast Cancer?

Another common question is whether hormone therapy causes breast cancer.

The answer depends on which hormones are being used.

The WHI found a modest increase in breast cancer risk among women taking a combination of conjugated equine estrogen (CEE) and the synthetic progestin medroxyprogesterone acetate (MPA).

However, women who received estrogen alone after hysterectomy actually experienced lower rates of breast cancer and lower breast cancer mortality during long-term follow-up.

One of the most important lessons from the WHI is that not all hormone therapies are the same.

Today's hormone therapy often uses bioidentical estradiol and micronized progesterone, which are different medications than those studied in the WHI. While additional research is ongoing, current evidence suggests these therapies may have different risk profiles than the older synthetic formulations.

Are All Forms of Estrogen the Same?

No.

One of the biggest misconceptions is that every form of estrogen carries the same risks.

In reality, the route of administration matters.

Transdermal estrogen is absorbed through the skin and bypasses the liver. This avoids many of the effects on clotting factors and triglycerides that can occur with oral estrogen.

Research suggests transdermal estradiol may carry a lower risk of blood clots and stroke than oral estrogen, particularly when used at lower doses.

This is one reason treatment should always be individualized rather than assuming every estrogen product has the same benefits and risks.

Why Did the FDA Remove the Boxed Warning?

After more than 20 years of additional research, the FDA concluded that applying the WHI findings to every hormone product, every dose, every route of administration, and every woman was no longer supported by the evidence.

The updated labeling now recognizes several important points:

• Different hormone formulations have different risk profiles.

• The timing of treatment matters.

• Treatment decisions should be individualized.

• The previous "lowest dose for the shortest time" recommendation has been replaced with a more personalized approach based on each woman's symptoms and health history.

This change reflects how menopause care has evolved over the past two decades.

What We Know Today

Current evidence supports several important principles:

• Hormone therapy remains the most effective treatment for moderate to severe hot flashes and other vasomotor symptoms.

• Starting therapy before age 60 or within 10 years of menopause generally offers the most favorable balance of benefits and risks.

• The type of estrogen, the route of administration, and whether progesterone is needed all matter.

• Individual risk factors, including cardiovascular health, personal and family history, and treatment goals, should guide decision-making.

What This Means for You

If you've been avoiding hormone therapy because of something you heard years ago, it may be time to revisit the conversation.

Hormone therapy is not right for everyone. However, for many healthy women who are within 10 years of menopause or younger than age 60, it can be a safe and highly effective treatment for hot flashes, night sweats, sleep disturbances, vaginal dryness, and other menopause symptoms.

The key is choosing the right treatment for the right patient.

There is no one-size-fits-all approach to menopause care. Your age, medical history, cardiovascular risk, family history, symptoms, and personal goals all play a role in determining whether hormone therapy is right for you and which formulation is the best fit.

Ready to Explore Your Options?

Menopause doesn't have to mean accepting poor sleep, hot flashes, mood changes, or feeling like you've lost yourself.

If you're wondering whether hormone therapy is right for you, I'd love to help. During a personalized consultation, we'll review your symptoms, medical history, lifestyle, and treatment goals to determine whether hormone therapy is an appropriate option for you. If it is, we'll create a personalized plan designed to help you feel your best while keeping your long-term health in mind.

Schedule your consultation today and take the first step toward feeling like yourself again.